What Are the Telltale Symptoms of Antiphospholipid Syndrome?

Published: Jan 23, 2024

Recognizing the symptoms of antiphospholipid syndrome (APS) early can lead to timely intervention and better health outcomes. Let's explore the key signs to watch for.

Common APS Symptoms

APS can present with a variety of symptoms, primarily due to blood clots forming in veins and arteries. Common signs include unexplained strokes, deep vein thrombosis, and pulmonary embolism. These symptoms often appear in younger individuals and may signal an underlying issue.

Pregnancy-Related Symptoms

In women, APS can lead to complications during pregnancy, such as recurrent miscarriages or preterm births. These complications are often linked to impaired blood flow to the placenta, highlighting the importance of monitoring during pregnancy for women with APS.

Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by recurring blood clots in veins and arteries, and complications during pregnancy such as recurrent miscarriages.

Skin and Neurological Symptoms

Some individuals with APS may experience skin changes like livedo reticularis, a lacy, purplish rash. Neurological symptoms can include headaches or cognitive difficulties, which may be related to small blood clots affecting the brain.

Frequently Asked Questions

APS symptoms include strokes, deep vein thrombosis, and pulmonary embolism.

APS can cause miscarriages and preterm births due to placental blood flow issues.

Yes, APS can cause livedo reticularis, a lacy rash on the skin.

Yes, small blood clots in the brain can lead to cognitive issues in APS.

Key Takeaways

Recognizing APS symptoms early is crucial for preventing severe complications.

Notice any symptoms? Consult Doctronic for a comprehensive evaluation.

Related Articles

References

Cervera R, Asherson RA. Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology 2003; 207:5.

Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112:682.

Always discuss health information with your healthcare provider.